Otsuka Pharmaceutical Development & Commercialization Inc.

Psychiatric Disorders

Clinical research in major depressive disorder includes adjunctive treatment strategies for incomplete response, alongside studies in generalised anxiety disorder and agitation associated with dementia.

  • Major depressive disorder
  • Generalised anxiety disorder
  • Agitation in dementia of the Alzheimer’s type

These studies reflect a focus on persistent mood and behavioural symptoms in adult psychiatric and neurocognitive conditions.

Autoimmune and Inflammatory Disease

The sponsor funds research in IgA nephropathy, immune-mediated focal segmental glomerulosclerosis, systemic lupus erythematosus, Sjögren’s disease, and plaque psoriasis.

  • IgA nephropathy
  • Systemic lupus erythematosus
  • Sjögren’s disease
  • Plaque psoriasis

Renal and systemic immune disorders are prominent areas of interest, with attention to both organ-specific and multisystem inflammatory disease.

Rare Kidney and Genetic Disorders

Research activity also extends to autosomal recessive polycystic kidney disease and phenylketonuria, highlighting interest in inherited conditions affecting childhood and lifelong disease management.

  • Autosomal recessive polycystic kidney disease
  • Phenylketonuria

These studies address rare disorders with significant renal or metabolic impact across paediatric and adult populations.

Infectious Disease

Trial activity includes work in tuberculosis, adding an infectious disease dimension to the sponsor’s research portfolio.

  • Tuberculosis

This area broadens the therapeutic scope beyond chronic immune, psychiatric, and genetic conditions.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria

    Recruiting

    3 1
    Investigated diseases:
    Czechia France Germany Italy The Netherlands Poland +1
  • Study on the Safety and Effects of Tolvaptan for Children with Autosomal Recessive Polycystic Kidney Disease (ARPKD)

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Poland Spain
  • Study on the Long-term Safety and Effectiveness of Sibeprenlimab for Patients with Immunoglobulin A Nephropathy (IgAN)

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Croatia Czechia France Germany Greece +6
  • Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated diseases:
    Bulgaria Denmark Estonia Germany Greece Poland +1
  • Study on AVP-786 for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated diseases:
    Belgium Croatia Hungary Ireland The Netherlands Slovakia +2
  • Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

    Not recruiting

    4 1 1
    Investigated diseases:
    Bulgaria Czechia Germany Hungary Poland Spain